Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000943559 | SCV001089509 | likely benign | Peroxisome biogenesis disorder 5A (Zellweger) | 2024-11-26 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001276116 | SCV001461967 | uncertain significance | Zellweger spectrum disorders | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003925846 | SCV004746969 | likely benign | PEX2-related disorder | 2019-10-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |